Emerging Infectious Diseases – 2025, 31, 8.  Nicolas M. Legrand, Rowena A. Bull, Behzad Hajarizadeh, Andrew R. Lloyd, Kirsty Johnston, Katya Issa, Christine Harvey, Alicia Arnott, Dominic E. Dwyer, Vitali Sintchenko, Luke Grant, Gregory J. Dore, John Kaldor, Marianne Martinello Abstract: Limited surveillance data have hindered understanding of SARS-CoV-2 transmission within prisons. We integrated routine…

Lancet Microbe 2025; 6: 101019 ESGMAC MAPS study group Abstract: Background: Mycoplasma pneumoniae is a major cause of respiratory tract infections. We aimed to investigate the spatiotemporal dynamics, antimicrobial resistance, and severity of the delayed re-emergence of infections with M pneumoniae after the implementation of non-pharmaceutical interventions (NPIs) against COVID-19. Methods:Epidemiological data (positive and total…

International Journal of Molecular Sciences – 2023, 24, 13387.  Aghazadeh, M.; Jones, M.; Perera, S.; Nair, J.; Tan, L.; Clark, B.; Curtis, A.; Jones, J.; Ellem, J.; Olma, T.; Stark, D.; Melki, J.; Coulston, N.; Baker, R. and Millar, D. Abstract: Globally, over 3.5 billion people are infected with intestinal parasites each year, resulting in…

By Dr. Douglas Millar and Dr. John Melki From the edited volume Dengue Fever in a One Health Perspective – Latest Research and Recent Advances published by IntechOpen, January 19th, 2023 Abstract We have developed a novel strategy to simplify microbial nucleic acids termed 3base™. This technology uses the chemical sodium bisulphite to reduce the…

Download our poster here.

View the publication here: Evaluation of the EasyScreen™ ESBL/CPO Detection Kit for the Detection of ß-Lactam Resistance Genes  

The need for accurate SARS-CoV-2 testing remains a priority. While nasopharyngeal (NP) swabs and PCR tests are considered the most sensitive and accurate, there is a need for simpler sample collection. Saliva has been investigated as an alternate sample type and validated in this study as a sampling method for SARS-CoV-2 detection. View our poster…

View our poster here: Evaluation of EasyScreenTM ESBL/CPO Detection Kit Using Direct-PCR from Patient Culture and Broth Samples

The article looks at our ongoing growth as an Australian biotech company and how our proprietary 3base technology has allowed us to respond to the COVID-19 pandemic, as well as accelerate global rollout of diagnostics for enterics, sexual health and a pipeline of new products. TechInvest Magazine 

N.A. Coulston, S.P. Siah, D.S. Millar. Specific Detection of High-Risk HPV Genotypes Using a Novel DNA Simplification Strategy. 17th ECCMID meeting, Munich, Germany 31 March – 3 April 2007